- Home
- NRC vs BNTC Comparison
NRC vs BNTC Comparison
Compare NRC & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRC | BNTC |
|---|---|---|
| Founded | 1981 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 390.8M | 411.4M |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NRC | BNTC |
|---|---|---|
| Price | $17.13 | $10.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $27.67 |
| AVG Volume (30 Days) | 100.0K | ★ 161.7K |
| Earning Date | 04-27-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.65% | N/A |
| EPS Growth | ★ 4707.69 | 80.94 |
| EPS | ★ 50.00 | N/A |
| Revenue | ★ $119,686,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.35 | ★ N/A |
| Revenue Growth | ★ 1.81 | N/A |
| 52 Week Low | $9.76 | $9.85 |
| 52 Week High | $22.79 | $17.15 |
Technical Indicators
Market Signals| Indicator | NRC | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 56.29 | 36.87 |
| Support Level | $14.78 | $10.10 |
| Resistance Level | $18.29 | $14.02 |
| Average True Range (ATR) | 0.91 | 0.64 |
| MACD | 0.15 | -0.13 |
| Stochastic Oscillator | 52.12 | 3.32 |
Price Performance
Historical ComparisonAbout NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.